Clinical Trial Update: A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPD [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 trial evaluating the safety and efficacy of oral LPCN 1154A in women with severe postpartum depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• LPCN 1154A

Snippet

Sponsor: Lipocine Inc. | Conditions: Depression, Postpartum, Depression, Post-Partum | Phase 3 | Status: COMPLETED